| Moderna and Pfizer-BioNTech say they're beginning trials to assess the safety, efficacy and dosage of their candidate vaccine that combines four flu strains and two coronavirus strains. | | News Alert Friday, November 11 | | | | | | | | | | | |
No comments:
Post a Comment